Treating chronic-stage stroke with hyperbaric oxygen therapy

Title : Treating chronic-stage stroke with hyperbaric oxygen therapy

Abstract:

Due to damage brought on by cerebrovascular occlusion or hemorrhage, the brain struggles to obtain the same amount of oxygen to the afflicted regions of a stroke. A novel protocol utilizing hyperbaric oxygen therapy (HBOT), has been proven to improve neurocognitive and neurological functions in post-stroke patients and promote neuroplasticity in recent studies. During this presentation, Dr. Amir Hadanny will present his most recent study and HBOT’s impact on cognitive function in post-stroke patients.

A retrospective analysis was conducted on patients who received HBOT for chronic stroke (>3 months) between 2008 and 2018. The protocol was performed in a multiplace hyperbaric chamber, where participants were subject to the 60 daily sessions in 12 weeks, 5 sessions a week for 90 minutes.

The study included 162 patients: 77 (47.53%) had cortical strokes, 87 (53.7%) strokes were located in the left hemisphere and 121 suffered ischemic strokes (74.6%). HBOT induced a significant increase in all the cognitive function domains (p < 0.05), with 86% of the stroke victims achieving a clinically significant improvement. In all cognitive domains, the baseline cognitive function was a significant predictor of improvement (p < 0.05), while stroke type, location and side were not significant predictors. Results continue to show that the unique HBOT protocol has made significant improvements in stroke recovery outcomes, even many years after the incident. The clinical improvements were achieved regardless of the type of stroke or where it occurred in the brain.

Audience Take Away

• Through the presentation of this research, the audience will learn about a unique and successful method that has been proven to reverse cognitive and physical damage that has occurred as a result of a stroke
• The research presented will provide hope for stroke survivors who suffer from post-stroke symptoms and impairments that were once thought to be chronic
• The audience will receive an in-depth analysis of what happens to the brain during a stroke and how the unique HBOT protocol can improve neurocognitive function in post-stroke patients and promote neuroplasticity

Biography:

Dr. Hadanny is the Chief Researcher and Head of Global Clinical Operations at Aviv Clinics. He is a certified neurosurgeon, hyperbaric physician, and Chief Medical Research Officer at the Sagol Center. For the past decade, he has worked alongside Dr. Shai Efrati researching neurorehabilitation, neuroplasticity and physiology, publishing more than 45 papers on the effects of HBOT on cognitive and physical performance. Before joining the Sagol Center, Dr. Hadanny was Chief Resident in the Galil Medical Center neurosurgery department. He earned his MD from Tel Aviv University and his Ph.D. in Bioinformatics and Machine Learning from Bar Ilan University.